The broader goal of the company is to explore its core patented technology, Pro-NP™ which has potent antioxidant property, for skincare and other dermal applications. The company is also exploring the use of Pro-NP™ in spinal injury.  Pro-NP™ is biodegradable and biocompatible and can deliver large molecular weight biologically active molecules in a sustained manner. ProTransit has exclusive licensing rights to the technology through UNeMed Corporation and Cleveland Clinic Innovation in addition to its own intellectual property.